The relationship between neurally mediated hypotension and the chronic fatigue syndrome

JAMA

Volumn 274, Issue 12, 1995, Pages 961-967

  Bou Holaigah, Issam ^a   Rowe, Peter C ^a   Kan, Jean ^a   Calkins, Hugh ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DISOPYRAMIDE; FLUDROCORTISONE;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR REFLEX; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPOTENSION; MALE; PRIORITY JOURNAL; SYMPTOMATOLOGY; TILTING;

EID: 0029126836     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.274.12.961     Document Type: Article

References (49)

1. Gunn WJ, Connell DB, Randall B. Epidemiology of chronic fatigue syndrome. Ciba Found Symp. 1993;173:83-101.
2. Lloyd AR, Hickie I, Boughton CR, Spencer O, Wakefield D. Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust. 1990;153:522-528.
3. Bates DW, Schmitt W, Buchwald D, et al. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med. 1993;153: 2759-2765.
4. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome. Ann Intern Med. 1988;108:387-389.
5. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome. Ann Intern Med. 1994;121:953-959.
6. Komaroff AL. Clinical presentation of chronic fatigue syndrome. Ciba Found Symp. 1993;173:43-61.
7. Lane RM. Aetiology, diagnosis and treatment of chronic fatigue syndrome. J Serotonin Res. 1994; 1:47-60.
8. Engel GL. Fainting: Physiological and Psychological Considerations. Springfield, I11: Charles C Thomas Publisher; 1950.
9. Weissler AM, Warren JV. Vasodepressor syncope. Am Heart J. 1959;57:786-794.
10. VanLieshout JJ, Wieling W, Karemaker JM, Eckberg DL. The vasovagal response. Clin Sci (Colch). 1991;81:575-586.
11. Kosinski DJ, Grubb BP. Neurally mediated syncope with an update on indications and usefulness of head-upright tilt table testing and pharmacologic therapy. Curr Opin Cardiol. 1994;9:53-64.
12. Sra JS, Jazayeri MR, Dhala A, et al. Neurocardiogenic syncope: diagnosis, mechanisms, and treatment. Cardiol Clin. 1993;11:183-191.
13. Calkins H, Shyr Y, Frumin H, Schork A, Morady F. The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and vasodepressor syncope. Am J Med. 1995;98:365-373.
14. Rowe PC, Bou-Holaigah I, Kan JS, Calkins H. Is neurally mediated hypotension an unrecognized cause of chronic fatigue? Lancet. 1995;345:623-624.
15. Straus SE, Dale JK, Tobi M, et al. Acyclovir treatment of the chronic fatigue syndrome. N Engl J Med. 1988;319:1692-1698.
16. Grubb BP, Wolfe DA, Samoil D, Temesy-Armos P, Hahn H, Elliott L. Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope. Pacing Clin Electrophyxiol. 1993;16:458-464.
17. Sheldon R, Killam S. Methodology of isoproterenol-tilt table testing in patients with syncope. J Am Clin Cardiol. 1992;19:773-779.
18. Sra J, Vishnubhakta SM, Jazayeri MR, et al. Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope. J Am Coll Cardiol. 1992;19:402-408.
19. Milstein S, Buetikofer J, Dunnigan A, Benditt DG, Gornick C, Reyes WJ. Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am J Cardiol. 1990;65:1339-1344.
20. Ross BA, Hughes S, Anderson E, Gillette PC. Abnormal responses to orthostatic testing in children and adolescents with recurrent unexplained syncope. Am Heart J. 1991;122:748-754.
21. Thilenius OG, Quinones JA, Husayni TS, Novak J. Tilt test for diagnosis of unexplained syncope in pediatric patients. Pediatrics. 1991;87:334-338.
22. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Med Care. 1988; 26:724-735.
23. Bentall RP, Wood GC, Marrinam T, Dears C, Edwards RHT. A brief mental fatigue questionnaire. Br J Clin Psychol. 1993;32:375-379.
24. Kramer MS, Feinstein AR. Clinical biostatistics, LIV: the biostatistics of concordance. Clin Pharmacol Ther. 1981;29:111-123.
25. Calkins H, Byrne M, El-Atassi R, Kalbfleisch S, Langberg JL, Morady F. The economic burden of unrecognized vasodepressor syncope. Am J Med. 1993;95:473-479.
26. Lewis T. A lecture on vasovagal syncope and the carotid sinus mechanism. BMJ. 1932;1:873-876.
27. Calkins H, Seifert M, Morady F. Clinical presentation and long term follow-up of athletes with exercise induced vasodepressor syncope. Am Heart J. 1995;129:1159-1164.
28. Grubb BP, Temesy-Armos PN, Samoil D, Wolfe DA, Hahn H, Elliott L. Tilt table testing in the evaluation and management of athletes with recurrent exercise-induced syncope. J Am Coll Sports Med. 1993;25:24-28.
29. Harrison MH, Kravik SE, Geelen G, Keil L, Greenleaf JE. Blood pressure and plasma renin activity as predictors of orthostatic tolerance. Aviat Space Environ Med. 1985;56:1059-1064.
30. Kleinknecht RA, Lenz J, Ford G, DeBerard S. Types and correlates of blood/injury level-related vasovagal syncope. Behav Res Ther. 1990;28:289-295.
31. Camfield PR, Camfield CS. Syncope in childhood. Can J Neurol Sci. 1990;17:306-308.
32. Kenny RA, Ingram A, Bayliss J, Sutton R. Head-up tilt: a useful test for investigating unexplained syncope. Lancet. 1986;1:1352-1355.
33. Almquist A, Goldenberg IF, Milstein S, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med. 1989;320:346-351.
34. Newman D, Lurie K, Rosenqvist M, Washington C, Schwartz J, Scheinman MM. Head-up tilt testing with and without isoproterenol infusion in healthy subjects of different ages. Pacing Clin Electrophysiol. 1993;16:715-721.
35. Fitzpatrick AP, Theodorakis G, Vardas P, Sutton R. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol. 1991;17:125-130.
36. Kapoor WN, Smith MA, Miller NL. Upright tilt testing in evaluating syncope: a comprehensive literature-review. Am J Med. 1994;97:78-88.
37. Sheldon R, Splawinski J, Killam S. Reproducibility of isoproterenol tilt-table tests in patients with syncope. Am J Cordiol. 1992;69:1300-1305.
38. Grubb BP, Wolfe D, Temesy-Armos P, Hahn H, Elliott L. Reproducibility of head upright tilt table test results in patients with syncope. Pacing Clin Electmphysiol. 1992;15:1477-1481.
39. Chen XC, Chen MY, Remote S, et al. Reproducibility of head-up tilt table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease. Am J Cardiol. 1992;69:755-760.
40. Peterson PK, Shepard J, Macres M, et al. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med. 1990;89:554-560.
41. Lloyd A, Hickie I, Wakelield D, Boughton C, Dwyer J. A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med. 1990; 89:561-568.
42. McEwen OR. Salt loss as a common cause of ill-health in hot climates. Lancet. 1935;1:1015.
43. McCanee RA. Experimental sodium chloride deficiency in man. Proc R Soc Land B Biol Sci. 1935-1936;119:245-268.
44. Best JB, Bett JHN, Coghlan JP, Cran EJ, Scoggins BA. Circulating angiotensin-II and aldosterone levels during dietary sodium restriction. Lancet. 1971;2:13534.
45. Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology. 1993;43:132-137.
46. Streeten DH, Anderson GH Jr. Delayed orthostatic intolerance. Arch Intern Med. 1992;152:1066-1072.
47. Rosen SG, Cryer PE. Postural tachycardia syndrome. Am J Med. 1982;72:847-850.
48. Fouad FM, Tadena-Thome L, Bravo E L, Tarazi RC. Idiopathic hypovolemia. Ann Intern Med. 1986; 104:298-303.
49. Price RK, North CS, Wessely S, Fraser VJ. Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community. Public Health Rep. 1992;107:514-522.